Thursday, April 20, 2023
3:00 PM – 4:00 PM (EST)


Watch Session

No registration is required to participate - the Series is free and open to anyone. To participate, log in with your username and password. Create a new, free account or for assistance with your existing login.

Melissa L. Johnson, MD - Moderator
Sarah Cannon Research Institute
Welcome and Introduction

Shun Lu, MD, PhD 
Shanghai Jiao Tong University
Abstract 425126: Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.

Tina Cascone, MD, PhD 
The University of Texas MD Anderson Cancer Center
Discussion of Abstract 425123

Panel Question and Answer with Drs. Lu and Cascone, moderated by Dr. Johnson

Toni K. Choueiri, MD - Moderator
Dana-Farber Cancer Institute

Shubham Pant, MD, MBBS
The University of Texas MD Anderson Cancer Center
Abstract 425082: KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRASG12C mutation. 

Elena Garralda, MD, MSc 
Vall d'Hebron University Hospital
Discussion of Abstract 425082

Panel Question and Answer with Drs. Pant and Garralda, moderated by Dr. Choueiri